MTNB · Matinas BioPharma Holdings, Inc.

NYSEHealthcareBiotechnology

Matinas Biopharma Holdings Inc Is A Clinical-Stage Biopharmaceutical Company With A Focus On Identifying And Developing Novel Pharmaceutical Products. The Firm'S Pipeline Includes Mat2203, Mat2501, And Others. Its Lnc Platform Enables Safe, Intracellular, Oral- Delivery Of Small Molecules And Small Oligonucleotides.

HealthcareNYSEUSUltra Low Float

$0.27

+34.2% latest move

Price & move as of the most recent catalyst (Aug 19) — not a live quote.

FLOAT

278.7K

FREE FLOAT %

28%

SHARES O/S

979.5K

MARKET CAP

$2.7M

EXCHANGE

NYSE

COUNTRY

MTNB Catalyst History

Products and ContractsExclusive Supplier DealJul 30, 2026 · 2:31pm ET

MTNBMatinas BioPharma Holdings, Inc.

GH Power and Matinas BioPharma Confirm Government of Canada Selects TKMS for Submarine Project

Post-merger stake stands at 91%.

Be early on the next MTNB spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →